DRUGLAB118 LTD
Significant control: Colin Lyon (75–100%)
From public filings as at 31 Aug 2026; may contain errors or be out of date. Verify at Companies House · Terms
Watch this company
Get an email when Companies House records a change for Druglab118 Ltd: status, filings, accounts, officers or owners. Free.
Not live yet: alerts start by 15 December 2026. We store your email and this company number only, for these alerts. If alerts don’t launch, we tell you and delete your address. Privacy
What does Druglab118 Ltd sell?
Registered activity: Manufacture of basic pharmaceutical products (SIC 21100). We’re building product and service lists for UK companies. Get this one when it’s ready.
Summary
DRUGLAB118 LTD is an active private limited company (company number 08447515) incorporated on 15 March 2013, registered in Darlington. Its registered activity is manufacture of basic pharmaceutical products (SIC 21100). Latest abridged accounts cover the period ending 31 March 2025, showing net assets of −£139k and cash of £2,322, with 2 employees on average. As abridged accounts, no profit and loss account is filed, so turnover and profit are not public. Net assets fell 1% on the prior period (−£137k).
By net assets it sits in the bottom quarter of 85 comparable companies in Other (median £7,540, upper quartile £306k).
Ownership and control
- Mr Colin Lyon
- owns 75–100% of shares
- holds 75–100% of voting rights
- Mr Stanley Irwin Grossman
- owns 25–50% of shares
- holds 25–50% of voting rights
Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents. Directors and secretaries: see the officers list at Companies House.
Key dates
- Incorporated
- 15 March 201313 yrs ago
- Next accounts due
- 31 December 2026in 67 days
- Confirmation statement due
- 29 March 2027in 155 days
Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.
Activity
- SIC 21100
- Manufacture of basic pharmaceutical products
- Accounts type
- Unaudited Abridged
- Size band
- MicroCompanies Act thresholds
Financials
| Period end | Net assets | Cash | Debtors | Creditors <1y | Turnover | Profit | Employees |
|---|---|---|---|---|---|---|---|
| 31 March 2025 | −£139k | £2,322 | £16k | — | — | — | 2 |
| 31 March 2024 | −£137k | £4,924 | £7,479 | — | — | — | 1 |
Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing.
Filing and accounts signals
- Net assets below zeroNet assets £-139,055 at 31 March 2025
- Incorporated five or more years agoIncorporated 15 March 2013
Neutral facts read from the register and filed accounts, each with its evidence. They are not a rating, a prediction or advice, and may be incomplete or out of date. How each signal is derived.
Timeline
- Confirmation statement duein 155 days
- Next accounts duein 67 days
- Accounts period endNet liabilities £139k · abridged accounts
- Accounts period endNet liabilities £137k · abridged accounts
- Incorporated
Similar companies in the UK
- CATALENT MTI PHARMA SOLUTIONS LIMITEDSwindon · inc. Dec 2012
- CAMBRIDGE HEALTHCARE SUPPLIES 2012 LIMITEDWymondham · inc. Oct 2012
- TYPHARM DEVELOPMENTS LIMITEDNorwich · inc. Oct 2012
- MRS RITCHIE LTD.Harrogate · inc. Aug 2013
- A & E HEALTHCARE LTDDumfries · inc. Aug 2012
- YORKSHIRE HYGIENE SOLUTIONS LIMITEDNorthallerton · inc. Aug 2012
All companies incorporated on 15 March 2013 · in Mar 2013.
Reminders for DRUGLAB118 LTD
Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.